Scarica l'app Stockscreener
281.89
4.00%
10.85
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$271.04
Aprire:
$269.42
Volume 24 ore:
846.44K
Relative Volume:
0.42
Capitalizzazione di mercato:
$42.57B
Reddito:
$4.39B
Utile/perdita netta:
$853.00M
Rapporto P/E:
51.16
EPS:
5.5097
Flusso di cassa netto:
$556.00M
1 W Prestazione:
+5.21%
1M Prestazione:
+4.41%
6M Prestazione:
+119.34%
1 anno Prestazione:
+180.91%
Intervallo 1D:
$266.20
$282.18
Intervallo di 1 settimana:
$257.31
$286.40
Portata 52W:
$94.00
$309.35
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, NTRA, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
281.89 | 42.57B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
695.80 | 257.27B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.26 | 163.28B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
412.74 | 59.49B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
178.06 | 50.20B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
464.06 | 45.59B | 3.77B | 449.25M | 240.68M | 7.8556 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2026-09-09 | Ripresa | UBS | Buy |
| 2026-06-26 | Ripresa | Bernstein | Mkt Perform |
| 2026-06-10 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2026-05-15 | Ripresa | RBC Capital Mkts | Outperform |
| 2026-05-14 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year - TradingView
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? - The Motley Fool
Illumina downgraded by Stephens with a new price target - Quantisnow
Should Illumina Stock Holders Look At Thermo Fisher Instead? - Trefis
Here’s How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Benzinga
Illumina, Inc. Estimates – NASDAQ:ILMN - TradingView
Illumina stock may move 9.3% on earnings release - Investing.com
Illumina: NovaSeq X And Consumables Sustain Momentum (NASDAQ:ILMN) - Seeking Alpha
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance - TradingView
Illumina's Stock Has Run Ahead Of Its Q3 Step-Down, Raising The Stakes On Clinical Demand - Finviz
Illumina Jumps 5.4% Amid Sector-Wide Rally - AlphaStreet
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina’s (ILMN) Strong Quarterly Beats on Revenue and Earnings Drive Share Gains - Yahoo Finance
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - Illumina
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - PR Newswire
Illumina, Inc. (ILMN) Launches Early-Access AI Genomics Tools - TradingView
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research
Single Cell Sequencing Market Forecast to 2035: Services, Technologies, End-users, Applications, and Regions | 15% CAGR Drives Drug Discovery and Precision Medicine Growth - GlobeNewswire Inc.
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research
In Brief This Week: Illumina, Interpace, Ocugen, Roots, Elicera, Verily, Quantum-Si, More - GenomeWeb
Illumina, Inc. (ILMN) Options Chain - Yahoo! Finance Canada
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TD Cowen lifts target for Illumina stock to USD 270.00 - ad-hoc-news.de
Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 Million - GlobeNewswire Inc.
$100 Invested In Illumina 15 Years Ago Would Be Worth This Much Today - Benzinga
Illumina 5-Base DNA Prep with Enzymatic Fragmentation - Illumina
Illumina Debuts BioInsight Platform, Expands AI Tools for Genomic Research - marketscreener.com
Illumina Consolidates Data Analysis Products Into New Platform, Pricing Model - GenomeWeb
Press Release - Illumina
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs - PR Newswire
Illumina, Inc. (ILMN) Launches BioInsight Platform With DRAGEN v4.6 - TradingView
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Zacks Investment Research
Did Illumina’s (ILMN) New SpliceAI2 Genomic Model Just Reframe Its Clinical Genomics Narrative? - Yahoo Finance
Illumina Launches $1.0 Billion Unsecured Commercial Paper Program; Signs Dealer Agreements - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Earnings Preview: What to Expect - Barchart.com
Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar? - Zacks Investment Research
Illumina’s (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself? - Yahoo Finance
Introducing SpliceAI2: The Next Generation of Splicing and Transcript Isoform Prediction - Illumina
Illumina Inc (ILMN) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 65/100 - GuruFocus
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Inc. Stock 12‑Month Price Target Raised to $237.16, Implies 10% Downside - TradingView
What is Illumina’s (ILMN) Economic Moat, and is it Widening or Narrowing? - Yahoo Finance
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 - Investing News Network
Illumina, Inc. Initiates Recall of NovaSeq 6000Dx Including DRAGEN Server And Illumina DRAGEN Server For NextSeq 550Dx - www.marketscreener.com
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 - Illumina
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Illumina Inc Azioni (ILMN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Corvex Management LP | Affiliate of Director (1) |
Sep 04 '26 |
Proposed Sale |
213.25 |
150,000 |
31,987,500 |
0 |
| Meister Keith A. | Director |
Sep 03 '26 |
Sale |
218.23 |
75,951 |
16,574,481 |
889,851 |
| Meister Keith A. | Director |
Sep 02 '26 |
Sale |
213.28 |
68,108 |
14,526,254 |
965,802 |
| Corvex Management LP | Affiliate of Director (1) |
Aug 27 '26 |
Proposed Sale |
224.84 |
200,000 |
44,968,000 |
0 |
| Meister Keith A. | Director |
Aug 27 '26 |
Sale |
228.89 |
138,379 |
31,673,778 |
1,033,910 |
| Meister Keith A. | Director |
Aug 26 '26 |
Sale |
225.46 |
106,543 |
24,021,247 |
1,172,289 |
| Corvex Management LP | Affiliate of Director (1) |
Aug 25 '26 |
Proposed Sale |
223.22 |
300,000 |
66,966,000 |
0 |
| Meister Keith A. | Director |
Aug 25 '26 |
Sale |
225.51 |
131,019 |
29,546,639 |
1,278,832 |
| Meister Keith A. | Director |
Aug 21 '26 |
Sale |
217.96 |
299,336 |
65,243,445 |
1,409,851 |
| Corvex Management LP | Affiliate of Director (1) |
Aug 21 '26 |
Proposed Sale |
213.24 |
250,000 |
53,310,000 |
0 |
1.26%
1.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):